Cholinesterase inhibitors for the treatment of delirium in non-ICU settings.

CONCLUSIONS: There is insufficient evidence to support or refute the use of cholinesterase inhibitors for the treatment of delirium in non-ICU settings. No clear benefits or harms associated with cholinesterase inhibitors were observed when compared with placebo due to the lack of data. More trials are required. PMID: 29952000 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29952000?dopt=Abstract

Source: Cochrane Database of Systematic Reviews - June 28, 2018 Category: General Medicine Authors: Yu A, Wu S, Zhang Z, Dening T, Zhao S, Pinner G, Xia J, Yang D Tags: Cochrane Database Syst Rev Source Type: research